Amgen Inc.

Amgen Inc.

33.10
CAD
+0.64
(+1.97%)
1.20EPS
22.19P/E
276.00BMarket Cap
Nov 03Next Earn

Valuation

Price vs. fair value · multiples
Price & Valuation BandSIGNATURE
Price against a fair-value channel (EPS × 12 / 15 / 23×)
+41.1% CAGR
Not enough positive-earnings history for a fair-value band

Growth

Revenue · EPS · free cash flow
Revenue
Top line with YoY growth
+5.4% CAGR
RevenueYoY growth
EPS (Diluted)
Per-share earnings · loss years read red
+4.6% CAGR
EPSYoY growth
Free Cash Flow
Operating CF − capex, with FCF margin
Operating CFCapexFree cash flowFCF margin

Profitability

Margins & returns on capital
Gross Profit & Margin
Bars with margin trend line
+3.6% CAGR
Gross profitGross margin
Operating Income & Margin
Bars with margin trend line
+0.7% CAGR
Operating incomeOperating margin
Net Income & Margin
Loss years read red
+1.1% CAGR
Net incomeNet margin
ROIC · ROE · ROA
Returns on capital · ROE on right axis
-0.7% CAGR
ROICROEROA

Balance Sheet Health

Liquidity · leverage · share count
Cash vs. Debt
Liquidity & leverage, net-debt line
Cash & investmentsTotal debtNet debt
Shares Outstanding
Diluted share count · buybacks vs. dilution
-3.4% CAGR
Dividends & Payout Ratio
Dividend per share with payout overlay
+11.7% CAGR
Dividend / sharePayout ratio
roic.ai · Fundamentals charts. Figures are not investment advice.